Zydus Lifesciences is strengthening its specialty and chronic care drug business as healthcare demand continues rising globally. The company is focusing on innovation-driven products and export expansion.
Growing healthcare awareness and demand for affordable medicines are supporting opportunities in the pharmaceutical sector. Zydus continues investing in research and regulatory approvals.
Experts believe the company’s diversified business model and international expansion strategy could support future growth.
